More specifically, eight manuscripts dealt with chemistry issues regarding the measurement of ApoB100, eight were associated with probiotics, prebiotics, and the gut microbiota, five manuscripts were associated with brain and/or neurogenerative disorders, four articles were associated with rheumatic/bone diseases, four concerned pediatric patients, three manuscripts were related to hypertension, and one was a book and not an article. Here, APOB is linked to hypertensive disorder.